Acute Hepatic Porphyria: Disease Diagnosis and Revelations Regarding the Role of siRNA Therapy
0.50 hr(s) | CME
Specialty: acute hepatic porphyria
Therapeutic Area(s): Gastroenterology , Emergency Medicine
Release Date: April 15, 2021
Expiration Date: April 14, 2022
Location: Internet Activity Enduring
In this activity, a leading expert in the management of acute hepatic porphyria (AHP) discusses recent evidence and recommendations for treating AHP and highlights the rationale and role of a new siRNA-based therapeutic option.